Fate Therapeutics Inc (FATE) — Long-term Investment Intensity
Fate Therapeutics Inc (FATE) has a Long-term Investment Intensity of 3.0% as of September 2025. Long-term investments of $10.30 Million represent 3.0% of total assets of $343.67 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Fate Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Fate Therapeutics Inc Long-term Investment Intensity (2019–2024)
This chart shows how Fate Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2019 to 2024. As of September 2025, the intensity stands at 3.0%, reflecting long-term investments of $10.30 Million against total assets of $343.67 Million USD. Explore Fate Therapeutics Inc (FATE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Fate Therapeutics Inc (2019–2024)
The table below presents the year-by-year Long-term Investment Intensity for Fate Therapeutics Inc from 2019 to 2024, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see FATE stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 6.3% | $27.66 Million | $440.69 Million | ▲ +6.1 pp |
| 2023 | 0.2% | $980.00K | $506.22 Million | ▼ -0.5 pp |
| 2022 | 0.7% | $4.94 Million | $705.56 Million | ▼ -10.2 pp |
| 2021 | 10.9% | $100.66 Million | $921.46 Million | ▼ -2.1 pp |
| 2019 | 13.0% | $39.44 Million | $302.27 Million | — |